Showing results (781-790 of 3,789) with videos related to

Sort By:
Pageof 379
Oncoimmunology|January 23, 2015
Forging a potent vaccine adjuvant: CpG ODN/cationic peptide nanoringsBilgi Gungor, Fuat Cem Yagci, Ihsan Gursel, et al.
Oncoimmunology|January 23, 2015
The pancreatic cancer microenvironment: an immunologic battlegroundVenu G Pillarisetty
Oncoimmunology|January 23, 2015
Chemotherapy-induced myeloid suppressor cells and antitumor immunity: The Janus face of chemotherapy in immunomodulationZhi-Chun Ding, David H Munn, Gang Zhou
Oncoimmunology|April 18, 2022
Cell-directed aptamer therapeutic targeting for cancers including those within the central nervous systemJun Wei, Renduo Song, Aria Sabbagh, et al.
Oncoimmunology|October 22, 2021
Trial watch: intratumoral immunotherapyJuliette Humeau, Julie Le Naour, Lorenzo Galluzzi, et al.
Oncoimmunology|October 22, 2021
CD8+ T lymphocytes are sensitive to NKG2A/HLA-E licensing interaction: role in the survival of cancer patientsLourdes Gimeno, Isabel González-Lozano, María F Soto-Ramírez, et al.
Oncoimmunology|July 28, 2022
Trogocytosis and fratricide killing impede MSLN-directed CAR T cell functionalityEsther Schoutrop, Stefanie Renken, Isabella Micallef Nilsson, et al.
Oncoimmunology|October 6, 2018
A point mutation in the Ncr1 signal peptide impairs the development of innate lymphoid cell subsetsFrancisca F Almeida, Sara Tognarelli, Antoine Marçais, et al.
Oncoimmunology|October 6, 2018
Tumor infiltrating CD19+ B lymphocytes predict prognostic and therapeutic benefits in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitorsZhiyuan Lin, Li Liu, Yu Xia, et al.
Oncoimmunology|October 6, 2018
Epigenetic treatment of multiple myeloma mediates tumor intrinsic and extrinsic immunomodulatory effectsLien De Beck, Sarah Melhaoui, Kim De Veirman, et al.
Pageof 379